1 in 11
new CASeS OF BreASt CAnCer per 100,000 women*
DeAthS CAuSeD By BreASt CAnCer per 100,000 women*
2020 new cases (incidence) and deaths (mortality) estimates
100.0 - 118.8 118.8 - 137.6 137.6 - 156.4 156.4 - 175.2 175.2 - 194.0
23.8 - 28.9 28.9 - 34.0 34.0 - 39.1 39.1 - 44.2 44.2 - 49.3
*Age-standardised rate (European new) per 100,000 *Age-standardised rate (European new) per 100,000
Breast cancer burden in EU-27
Source: ECIS – European Cancer Information System https://ecis.jrc.ec.europa.eu, accessed 15/10/2020 ©European Union, 2020
355,457 91,826
Breast cancer is a malignant tumour that has developed from cells in the breast.
It usually begins either in the cells of the lobules (the milk-producing glands) or in the ducts that drain the milk from the lobules to the nipple. Less commonly, breast cancer can begin in the stromal tissues, which include the fatty and fibrous connective tissues of the breast.
It is estimated that breast cancer accounts for 13.3% of all new cancer cases diagnosed in EU-27 countries in 2020. This makes it the most frequently occuring cancer. It is estimated that it accounts for 28.7% of all new cancers in women.
lifetime risk (ages 0-74) of developing breast cancer
new cases deaths
Joint Research Centre
Year
new CASeS OF BreASt CAnCer – all ages, per 100,000 women
• Breast cancer is estimated to be the most diagnosed tumour among all cancer types and the first cause of cancer death among women in 2020.
• Estimated breast cancer incidence and mortality rates in 2020 vary two-fold across EU-27.
• Incidence trends in the EU-27 are mainly increasing. Multiple factors explain these changes, including reproductive factors, increasing obesity and physical inactivity as well as increased screening intensity.
• Mortality trends in the EU-27 tend to be in decline. This is mainly due to effective treatment and tools for detecting the disease at early stages.
• The five-year survival of breast cancer patients diagnosed in 2000-2007 is highest in Northern and Western Europe and lowest in Eastern Europe. National differences can in part be explained by varying levels of healthcare expenditure and resulting quality of diagnosis and treatment.
Year
tempOrAl trenDS In SeleCteD COuntrIeS
BreASt CAnCer SurVIVAl
Ages >15, cancers diagnosed in 2000-2007
Percentage of women who survived at least 5 years after diagnosis
eStImAteD DIStrIButIOn OF new CASeS OF BreASt CAnCer In 2020 – By AGe GrOup
The Netherlands
The Netherlands Czech Republic Czech Republic
Finland France
Sweden Italy
Belgium
Germany The Netherlands
Spain
Ireland Slovenia Slovakia
Estonia Poland
Portugal Austria Denmark Malta
Czech Republic Croatia
Bulgaria
Lithuania Latvia
Grateful acknowledgement is given to the European cancer registries as the data source for the indicators reported in the
european Cancer Information System (eCIS).
This factsheet reports information from ECIS.
For details, please visit:
https://ecis.jrc.ec.europa.eu or scan this QR code:
https://cancer-code-europe.iarc.fr In collaboration with IARC, IACR, and EUROCARE
DeAthS CAuSeD By BreASt CAnCer – all ages, per 100,000 women
Age-standardised rate (European standard popu- lation, 2013) — new cases per 100,000 women Age-standardised rate (European standard popu- lation, 2013) — deaths per 100,000 women
0 75
100 125 150 175 200
25 50 75 100
The examples (one from each European region: Central and Eastern, Northern, Southern, Western) are selected from available incidence and mortality time series of at least 20 years, from the ECIS web application archive (https://ecis.jrc.ec.europa.eu), complemented with the official mortality statistics from EUROSTAT (HLTH_CD_ASDR, HLTH_CD_ASDR2) for Slovenia.
9 cases
0-19 20-44 45-69 70+
191,955 cases 122,880 cases 40,613 cases
hIGhlIGhtS
Slovenia
Slovenia Denmark
Denmark
1994 1994
2000
2000 2007
2007
1997 1997
2004 2004
2003 2003
201 0 201
0
1996 1996
2002 2002
2009
2009 1999
1999 2006
2006
2005 2005
201 2 201
2
1995 1995
2001 2001
2008 2008
1998
1998 2011
2011
2013 2013
10 20 30 40 50 60 70 80 90 100
